IR-MED’s PressureSafe™ Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries
April 05, 2024 09:00 ET
|
IR-Med, Inc.
Marks major milestone prior to launch in U.S. marketPressureSafe™ scanner and disposable pack both listed with FDAPressureSafe™ can support early detection of pressure injuries, potentially setting a...
IR-MED Appoints Richard Serbin, Esq. to its Advisory Board
September 13, 2023 09:15 ET
|
IR-Med, Inc.
Served as Chief FDA Counsel for Revlon and Johnson & Johnson, as a Board Member at Johnson & Johnson Development Corporation, that company’s strategic venture capital division, and as patent...
IR-Med to present at National Pressure Injury Advisory Panel 2023
March 14, 2023 09:00 ET
|
IR-Med, Inc.
The company’s PressureSafe device is being designed to reduce healthcare disparity in pressure injury detection and treatment Rosh Pina, Israel, March 14, 2023 (GLOBE NEWSWIRE) -- “IR-MED” or the...
IR-Med Announces Dr. David Dalton as Advisory Board member
November 16, 2022 09:32 ET
|
IR-Med, Inc.
Dr. Dalton brings decades of experience as a hall of fame CEO, entrepreneur, pharmaceutical executive and founder of over 40 companies Rosh Pinna, Israel, Nov. 16, 2022 (GLOBE NEWSWIRE) --...
IR-Med files Provisional Patent Application Covering Additional Features of its PressureSafe Device for Early Detection of Pressure Injuries
August 12, 2022 08:34 ET
|
IR-Med, Inc.
Rosh Pinna, Israel, Aug. 12, 2022 (GLOBE NEWSWIRE) -- (“IR-MED or the “Company”) (OTCQB:IRME), an innovative medical device company, developing non-invasive, real-time detection devices that utilize...